Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy

Benevento

Tucson

Los Angeles

Orange

Washington D.C.

Gainesville

Chicago

Westwood

New Orleans

Scarborough

Boston

Detroit

Minneapolis

Hackensack

New York

Philadelphia

Charleston

Dallas

Galveston

Houston

Seattle

Ciudad Autonoma de Buenos Aires

Buenos Aires

Pilar

Camperdown

Heidelberg

Melbourne

Nedlands

Graz

Innsbruck

Linz

Vienna

Brussels

Ghent

Leuven

Liège

Porto Alegre

São Paulo

Barretos

Rio de Janeiro

Vancouver

Toronto

Amiens

Bordeaux

Caen

Clichy

Créteil

Grenoble

Lille

Marseille

Montpellier

Paris

Reims

Rennes

Toulouse

Villejuif

Aachen

Berlin

Bonn

Düsseldorf

Essen

Frankfurt am Main

Hamburg

Hanover

Heidelberg

Leipzig

Magdeburg

Mainz

Munich

München

Regensburg

Tübingen

Ulm

Würzburg

Meldola

Rozzano

Orbassano (TO)

Bergamo

Bologna

Catania

Florence

Milan

Modena

Napoli

Padua

Parma

Pavia

Pisa

Reggio Emilia

Roma

Turin

Amsterdam

Auckland

Lisbon

Porto

Vila Real

Santiago de Compostela

Majadahonda

Pamplona

Oviedo

Alicante

Barcelona

Córdoba

Madrid

Sabadell

Santander

Valencia

Zaragoza

Gothenburg

Stockholm

Bern

Zurich